Lists of diseases

Encompass Health Rehabilitation Hospital of Waco now open

Retrieved on: 
Monday, August 2, 2021
Hospitals, Rehabilitation hospital, Encompass Health, Health care, Medicine

BIRMINGHAM, Ala. and Waco, Texas, Aug. 2, 2021 /PRNewswire/ --Encompass Health (NYSE: EHC), the nation's largest owner and operator of inpatient rehabilitation hospitals, announces the opening of Encompass Health Rehabilitation Hospital of Waco, a 40-bed inpatient rehabilitation hospital located at 3600 S Loop 340 Highway in Robinson, Texas.

Key Points: 
  • BIRMINGHAM, Ala. and Waco, Texas, Aug. 2, 2021 /PRNewswire/ --Encompass Health (NYSE: EHC), the nation's largest owner and operator of inpatient rehabilitation hospitals, announces the opening of Encompass Health Rehabilitation Hospital of Waco, a 40-bed inpatient rehabilitation hospital located at 3600 S Loop 340 Highway in Robinson, Texas.
  • In addition to 24-hour nursing care, Encompass Health Rehabilitation Hospital of Waco offers physical, occupational and speech therapies to restore functional ability and quality of life.
  • "Encompass Health is committed to making a difference in the communities we serve by improving access to high-quality, individualized rehabilitative care," said Mark Tarr, president and chief executive officer for Encompass Health.
  • Encompass Health Rehabilitation Hospital of Waco is Encompass Health's 141st inpatient rehabilitation hospital and its 26th inpatient rehabilitation hospital in Texas.

SK Life Science, Inc. Launches STEPS Toward Zero Movement to Educate, Inspire and Activate the Epilepsy Community

Retrieved on: 
Monday, August 2, 2021
Epilepsy

We hope the STEPS Toward Zero movement inspires more discussion among members of the epilepsy community."

Key Points: 
  • We hope the STEPS Toward Zero movement inspires more discussion among members of the epilepsy community."
  • Additionally, as a part of the STEPS Toward Zero movement, SK life science is inviting the epilepsy community to join the conversation and share what zero seizures means to them by using #STEPSTowardZero on social media.
  • "SK life science's STEPS Toward Zero movement provides another platform to put the brains and stories of people with epilepsy at the center of conversations in order to facilitate education and connections and inspire others in the epilepsy community."
  • Epilepsy.

Streamlining Brain Tumor Surgery Care During the Pandemic

Retrieved on: 
Monday, August 2, 2021
Medical specialties, Clinical medicine, Medicine, Neurosurgical procedures, Intensive care medicine, Intensive care unit, Craniotomy, Brain tumor

As U.S. health care eventually emerges from the pandemic, many aspects of surgical care, including how patients are prepared for surgery and where and how they recover will be forever altered.

Key Points: 
  • As U.S. health care eventually emerges from the pandemic, many aspects of surgical care, including how patients are prepared for surgery and where and how they recover will be forever altered.
  • The pandemic's strain on hospital ICUs and other facilities forced the PNI and Saint John's teams to reconsider some basic assumptions about brain tumor care and rapidly implement protocol enhancements that already had been in use on a more limited basis.
  • "Brain tumor surgery by craniotomy or endonasal removal is resource intensive and historically has required multi-day hospital admissions, often including recovery in the ICU," Dr. Kelly added.
  • There were no differences pre-pandemic versus pandemic in tumor removal rates, complications, readmissions or reoperations.

Delix Therapeutics Continues Rapid Growth with Appointment of Chief Medical Officer

Retrieved on: 
Monday, August 2, 2021
Robertson, Surnames

BOSTON, Aug. 2, 2021 /PRNewswire/ -- Preclinical neuroscience company Delix Therapeutics (the "Company"), today announced the appointment of Dr. Brigitte Robertson as Chief Medical Officer.

Key Points: 
  • BOSTON, Aug. 2, 2021 /PRNewswire/ -- Preclinical neuroscience company Delix Therapeutics (the "Company"), today announced the appointment of Dr. Brigitte Robertson as Chief Medical Officer.
  • Dr. Robertson joins the company from Yumanity Therapeutics, where she served as Chief Medical Officer since 2019.
  • "Delix is fortunate to have Dr. Robertson and her unmatched experience developing scientifically rigorous medicines and safely bringing them to the market," said Delix Therapeutics CEO Mark Rus.
  • Delix co-founder Dr. David E. Olson was named Chief Innovation Officer and head of Delix's Scientific & Strategic Advisory Board.

Oak Health Center Opens New Beverly Hills Location

Retrieved on: 
Monday, August 2, 2021
Health, Articles, Primary care, Disability, Mental health, Positive psychology, Social constructionism, Health care

BEVERLY HILLS, Calif., Aug. 2, 2021 /PRNewswire-PRWeb/ --Oak Health Center, Southern California's premier comprehensive mental health outpatient care organization, is pleased to announce the opening of its new Beverly Hills office location, ready to provide the community with the same level of quality care that Oak Health is known for.

Key Points: 
  • BEVERLY HILLS, Calif., Aug. 2, 2021 /PRNewswire-PRWeb/ --Oak Health Center, Southern California's premier comprehensive mental health outpatient care organization, is pleased to announce the opening of its new Beverly Hills office location, ready to provide the community with the same level of quality care that Oak Health is known for.
  • Oak Health Center was originally founded in 2015 with the purpose of giving the communities they serve an easy way to access comprehensive and compassionate mental healthcare.
  • Discussing the new location, Practice Manager Andrew Brewer had this to say: "We are very excited to expand our offerings in Beverly Hills.
  • Oak Health Center offers comprehensive mental health outpatient care through our team of psychiatrists, nurse practitioners, psychologists, therapists, and tele-behavioral health clinicians.

LISCure Biosciences Announces Know-How License Agreement and Stock Purchase Agreement with Mayo Clinic

Retrieved on: 
Monday, August 2, 2021
Hepatitis, Mayo Clinic, Steatohepatitis, Mayo, Non-alcoholic fatty liver disease, Minnesota, States of the United States, Medicine

SEOUL, South Korea, Aug. 1, 2021 /PRNewswire/ -- LISCure Biosciences, Inc. ("LISCure") has entered into a know-how license and development collaboration agreement, and stock purchase agreement with Mayo Clinic to advance LISCure's microbiome therapeutics in non-alcoholic steatohepatitis (NASH).

Key Points: 
  • SEOUL, South Korea, Aug. 1, 2021 /PRNewswire/ -- LISCure Biosciences, Inc. ("LISCure") has entered into a know-how license and development collaboration agreement, and stock purchase agreement with Mayo Clinic to advance LISCure's microbiome therapeutics in non-alcoholic steatohepatitis (NASH).
  • Under the agreement, the company will receive Mayo Clinic's know-how to establish a new drug development of NASH program.
  • As part of the agreement, Mayo Clinic will become a shareholder in LISCure, the first Korean biotech company receiving equity investment from Mayo Clinic.
  • "We are also proud of Mayo Clinic becoming our shareholder and look forward to continuing a long-term collaboration."